BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30978727)

  • 1. The Case for an Estrogen-iron Axis in Health and Disease.
    Hamad M; Bajbouj K; Taneera J
    Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):270-277. PubMed ID: 30978727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer.
    Jian J; Yang Q; Dai J; Eckard J; Axelrod D; Smith J; Huang X
    Free Radic Biol Med; 2011 Apr; 50(7):841-7. PubMed ID: 21193031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of iron metabolism in health and disease.
    Dev S; Babitt JL
    Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S6-S20. PubMed ID: 28296010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cycle arrest in MCF-7 cells.
    Bajbouj K; Shafarin J; Abdalla MY; Ahmad IM; Hamad M
    Tumour Biol; 2017 Oct; 39(10):1010428317726184. PubMed ID: 29022497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin and metallothioneins as molecular base for sex-dependent differences in clinical course of experimental autoimmune encephalomyelitis in chronic iron overload.
    Ćurko-Cofek B; Grubić Kezele T; Barac-Latas V
    Med Hypotheses; 2017 Sep; 107():51-54. PubMed ID: 28915963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors and human disease.
    Deroo BJ; Korach KS
    J Clin Invest; 2006 Mar; 116(3):561-70. PubMed ID: 16511588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms.
    Enculescu M; Metzendorf C; Sparla R; Hahnel M; Bode J; Muckenthaler MU; Legewie S
    PLoS Comput Biol; 2017 Jan; 13(1):e1005322. PubMed ID: 28068331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-dependent changes in serum iron levels as a translator of the adverse effects of estrogen during infection: a conceptual framework.
    Hamad M; Awadallah S
    Med Hypotheses; 2013 Dec; 81(6):1130-4. PubMed ID: 24211145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin: A key regulator of iron.
    Saneela S; Iqbal R; Raza A; Qamar MF
    J Pak Med Assoc; 2019 Aug; 69(8):1170-1175. PubMed ID: 31431773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological focus on the erythropoietin-hepcidin-ferroportin axis.
    D'Anna MC; Roque ME
    Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element.
    Hou Y; Zhang S; Wang L; Li J; Qu G; He J; Rong H; Ji H; Liu S
    Gene; 2012 Dec; 511(2):398-403. PubMed ID: 23041085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.
    Millot S; Delaby C; Moulouel B; Lefebvre T; Pilard N; Ducrot N; Ged C; Lettéron P; de Franceschi L; Deybach JC; Beaumont C; Gouya L; De Verneuil H; Lyoumi S; Puy H; Karim Z
    Haematologica; 2017 Feb; 102(2):260-270. PubMed ID: 28143953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Abnormal Iron Metabolism on Osteoporosis.
    Che J; Yang J; Zhao B; Zhang G; Wang L; Peng S; Shang P
    Biol Trace Elem Res; 2020 Jun; 195(2):353-365. PubMed ID: 31473898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
    Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload.
    Bi Y; Ajoolabady A; Demillard LJ; Yu W; Hilaire ML; Zhang Y; Ren J
    Biochem Pharmacol; 2021 Aug; 190():114661. PubMed ID: 34157296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepcidin and ferroportin in iron absorption.
    Oates PS
    Histol Histopathol; 2007 Jul; 22(7):791-804. PubMed ID: 17455153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the regulation of iron homeostasis.
    Deicher R; Hörl WH
    Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis.
    Qian Y; Zhang S; Guo W; Ma J; Chen Y; Wang L; Zhao M; Liu S
    Chem Res Toxicol; 2015 Apr; 28(4):629-40. PubMed ID: 25686467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
    Stevenson JC
    Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.